Progress in human ovarian rejuvenation: Current platelet-rich plasma and condensed cytokine research activity by scope and international origin

9Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Objective: As clinicians and patients await consensus on intraovarian platelet-rich plasma (PRP) treatment, this project evaluated contemporary research trends in the literature. Methods: A PubMed/NLM search aggregated all ovarian PRP-related publications (n=54) to evaluate their scope, abstract utility, submission-to-publication interval, journal selected, article processing charge (APC), free reader access to full-text manuscripts, number and nationality of authors, and inclusion of international collaborators. The NIH Clinical Trials database was also audited. Results: Published output on intraovarian PRP has increased consistently since 2016, especially among investigators in Greece, Iran, USA, and Turkey. Between 2013 and 2021, 42 articles met the relevancy criteria, of which 40.5% reported clinical studies, small series, or case reports, 33% described experimental animal models, and 23.8% were opinion/review papers. Only two works included a placebo control group. The submission-to-publication interval (mean±standard deviation) was 130±96 days, there were 5.9±3.2 authors per project, and journals invoiced US $1,613±1,466 (range, $0–$3,860) for APCs. Conclusion: There was no correlation between APC and time to publish (Pearson’s r=–0.01). Abstract content was inconsistent; sample size and patient age were often missing, yet free full-text “open access” was available for most publications (59.5%). The NIH Clinical Trials portal lists eight registered studies on “ovarian rejuvenation,” of which two are actively recruiting patients, while four have been terminated or have an uncertain status. Two studies have concluded, with results from one posted to the NIH website. PRP and its derivatives for ovarian treatment show early promise, but require further investigation. Research is accelerating and should be encouraged, particularly placebo-controlled randomized clinical trials.

References Powered by Scopus

Open access publishers: The new players

32Citations
N/AReaders
Get full text

A PRISMA assessment of the reporting quality of systematic reviews of nursing published in the Cochrane Library and paper-based journals

22Citations
N/AReaders
Get full text

Equipoise and the RCT

19Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Nature and characteristics of global attention to research on article processing charges

6Citations
N/AReaders
Get full text

Ovarian recovery via autologous platelet-rich plasma: New benchmarks for condensed cytokine applications to reverse reproductive aging

6Citations
N/AReaders
Get full text

Beneficial effects of intraovarian injection of plateletrich plasma in women with poor ovarian respons

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sills, E. S., & Wood, S. H. (2021). Progress in human ovarian rejuvenation: Current platelet-rich plasma and condensed cytokine research activity by scope and international origin. Clinical and Experimental Reproductive Medicine, 48(4), 311–315. https://doi.org/10.5653/cerm.2021.04651

Readers over time

‘22‘23‘2401234

Readers' Seniority

Tooltip

Professor / Associate Prof. 2

67%

PhD / Post grad / Masters / Doc 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

60%

Business, Management and Accounting 1

20%

Social Sciences 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0